By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series
The AI Helping Manage Chronic Diseases panel at 4D Meets AI discusses the detection, prevention, and intelligent agents treating and managing the stages inherent in chronic disease. AI is supporting increased data volume, improving personalized therapy for patients, in addition to providing more access to patients for daily management. The panel covers a diverse range of chronic disease and solutions providing clinicians with up-to-date information for optimal therapeutic decision-making and patients with the information they need to live happy and healthy lives.
The pre-recorded panel will be part of 4D Meets AI digital partnering conference, taking place September 17-18, 2020.
Moderator: Rick Berenson, CEO, Thermalin
Artificial intelligence (AI) and sensor technology used in implantable and wearable devices and managed care solutions use smart, natural language-based agents to help clinicians and patients with chronic disease management. Rick co-founded Thermalin, which is developing the StampPump – a postage-stamp-sized, wearable, intelligent glucose management system for people with T1 and T2 diabetes. As a connected sensor platform, StampPump will deliver continuous metabolic telemetry that, with the assistance of machine learning algorithms, will enable physicians to better coach diabetes patients and fine-tune their glucose control algorithms. Rick raised the funding, built the scientific and business teams, and drives the company’s strategy. Rick received a JD-MBA from Harvard Business and Law Schools in 1984, then worked for Bell Laboratories and an AI startup before joining McKinsey & Company. He subsequently became a serial entrepreneur who has previously launched and financed multiple life science organizations.
Paul Pyzowski, Founder & CEO, Altimate Health
Paul Pyzowski is the founder and CEO of Altimate Health. Altimate is leading the development of precision psychiatry, applying data science to identify and guide treatment for patients with psychiatric and other behavioral health disorders. Paul has a diverse entrepreneurial and executive background that includes Parkinson’s disease therapeutics, therapies for pediatric epilepsy, rapid DNA sequencing, clinical laboratories for addiction medicine, and computational physics. BSEE from Carnegie-Mellon, MBA from the Institute for Management Development in Switzerland.
Kim Shah, MBA, CEO, KnowYourMeds
Shah was most recently Global Director of Marketing for the Informatics Software business within Thermo Fisher Scientific, a $20 Billion company whose mission is to enable their customers to make the world healthier, cleaner and safer. During his career, Shah has held executive level positions at a number of high-tech companies such as Lotus Development, Micrografx and Inso Corporation. Shah is an experienced Marketing Executive with a demonstrated history of working in the research industry. Skilled in Product Management, Advertising, Enterprise Software, Sales, Entrepreneurship, and Customer Relationship Management (CRM). Strong marketing professional with an MBA focused in Business Administration from MIT Sloan School.
Karolina Starczak, MS, CEO, Nutrimedy
Karolina is currently the CEO of Nutrimedy, a digital health solution focused on transforming clinical nutrition care in oncology, heart failure, kidney disease, and inflammatory bowel disease. As a registered and licensed clinical dietitian, Karolina incorporates her multi-dimensional background in healthcare to uncover innovative solutions aimed at addressing cost drivers and improving health outcomes. Over the past 15 years, her career evolved from the emergency services field to digital startups and workplace wellness. From small local employers to Fortune 500 companies, Karolina has led and designed data-driven, award-winning programs that improve employee wellbeing and help curtail future healthcare spend. Karolina received her BS in Nutrition and Food Science from Montclair State University, completed her post-baccalaureate dietetic residency at Rutgers University, and completed her Master in Healthcare Leadership at Brown University.
For over 25 years, Robert Garber has worked with early-stage healthcare and technology companies, co-managing three venture funds with $200M+AUM and holding leadership positions with three high-growth companies. Robert is currently a Partner at 7wire Ventures, where he focuses on investments in digital healthcare and technology-enabled services that empower consumers to be better stewards of their health and healthcare expenditures. 7wireVentures is an early stage, healthcare venture firm that supports entrepreneurs who focus on empowering the Connected Informed Health Consumer to create great companies and change the status quo. 7wire believes that mobile, connected platforms, the cloud, and sophisticated insights will improve the efficiency of the healthcare system and improve outcomes for all.
Evan is part of the investment team for the DaVita Venture Fund. Previously, he led M&A and strategic payer activities at Genoa Healthcare (OptumRx division), the country’s leading behavioral health pharmacy, telepsychiatry and medication management services company. Evan joined Genoa Healthcare through the acquisition of 1DocWay, where
Roy Wiesner is a Managing Director at aMoon Fund, Israel’s largest life sciences and healthtech VC. He focuses on early-stage investments, primarily in digital health and medical devices. Prior to joining aMoon, he was the CEO of a Cleantech incubator and seed-stage fund owned by CK Hutchison (Fortune 500 company), where he was also involved in forming a number of ventures. Roy was previously a corporate lawyer, specializing in M&A, Private Equity and VC transactions, working for international law firm Weil Gotshal in New York and Hong Kong, and as a partner for a prominent law firm in Tel Aviv. He holds an LL.B from the Hebrew University and a dual MPA from the LSE and Columbia University.
Ben started his career as a doctor in the NHS before working in the UK and US across early stage medtech, management consultancy and hospital management. He has a particular interest in technologies that can improve the working lives of clinical and non-clinical healthcare staff.
Netalie has 20 years of professional experience in technology start-up and global corporate environments. Netalie’s interdisciplinary and holistic background, working with start-ups from different vantage points throughout her career, contributes greatly to the evaluation and identification of investment opportunities and portfolio management.
